Brandes Investment Partners LP Acquires 1,900 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Brandes Investment Partners LP increased its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 35.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,332 shares of the company’s stock after purchasing an additional 1,900 shares during the quarter. Brandes Investment Partners LP’s holdings in Henry Schein were worth $470,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. TD Asset Management Inc increased its stake in shares of Henry Schein by 8.6% in the fourth quarter. TD Asset Management Inc now owns 35,644 shares of the company’s stock valued at $2,699,000 after buying an additional 2,812 shares during the period. Treasurer of the State of North Carolina increased its position in Henry Schein by 0.9% during the 4th quarter. Treasurer of the State of North Carolina now owns 67,078 shares of the company’s stock valued at $5,078,000 after purchasing an additional 605 shares during the period. Bank of Nova Scotia raised its holdings in Henry Schein by 33.3% during the 4th quarter. Bank of Nova Scotia now owns 16,195 shares of the company’s stock worth $1,226,000 after purchasing an additional 4,044 shares during the last quarter. California State Teachers Retirement System lifted its position in shares of Henry Schein by 1.1% in the 4th quarter. California State Teachers Retirement System now owns 208,574 shares of the company’s stock worth $15,791,000 after purchasing an additional 2,308 shares during the period. Finally, KBC Group NV boosted its stake in shares of Henry Schein by 163.5% in the 4th quarter. KBC Group NV now owns 521,964 shares of the company’s stock valued at $39,518,000 after purchasing an additional 323,901 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Stock Performance

Henry Schein stock opened at $72.90 on Tuesday. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. The firm has a market cap of $9.33 billion, a P/E ratio of 24.63, a P/E/G ratio of 2.01 and a beta of 0.86. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $82.63. The firm has a 50-day moving average of $70.14 and a 200-day moving average of $70.17.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. The business had revenue of $3.10 billion for the quarter, compared to the consensus estimate of $3.27 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The company’s quarterly revenue was up .0% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.31 EPS. Sell-side analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

Insider Buying and Selling

In other news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 1.14% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

HSIC has been the subject of a number of analyst reports. Evercore ISI lowered their target price on shares of Henry Schein from $72.00 to $70.00 and set an “in-line” rating for the company in a research note on Wednesday, August 7th. JPMorgan Chase & Co. dropped their price objective on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research note on Monday, August 12th. Robert W. Baird decreased their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. Barrington Research reissued an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a research note on Friday, September 20th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $86.00 price objective on shares of Henry Schein in a research report on Friday, June 21st. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $77.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.